Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Overview of a yearly tax planning approach for index fund losses, detailing steps to track opportunities, document losses, and optimize filings.
19,656 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Tuniu faces a shifting travel landscape as 2026 unfolds. This guide breaks down what to watch in tuniu (tour) 2026 ea...
A leading cloud giant reportedly inks a multi-year deal with a niche semiconductor maker. This article breaks down wh...
A sudden pullback in a high-profile space stock captured headlines. This article breaks down the factors behind intui...
Vanguard’s 2026 retirement snapshot reveals a paradox: record average balances mask a steep median gap, underscoring ...
Broadcom’s latest results point to strong AI-chip momentum even as the market reacts. This article breaks down what t...
When sandisk stock just dropped, it sent ripples through a volatile memory market. This article breaks down the drive...
Microsoft stock has pulled back in a surprising turn for a tech giant. This article unpacks the reasons behind the dr...
CoreWeave stock is front and center as data-center demand rises. With a growing backlog and expanding capacity plans,...
Berkshire Hathaway faces a pivotal July 22 shareholder vote on a major housing bet. This deep dive explains what’s at...
CoreWeave’s stock suffers another long selloff as investors weigh debt exposure against growth in the AI cloud market...
An external review shows the Gates Foundation met with Jeffrey Epstein roughly 30 times between 2011 and 2014, despit...